Zusammenfassung
Zwillingsanalysen legen für etwa 35% der kolorektalen Karzinome (CRC) einen familiären Hintergrund nahe, derzeit sind jedoch die molekularen Grundlagen nur bei etwa 5–10% der Fälle weitergehend aufgeklärt. Diese im engeren Sinne „erblichen“ Formen des CRC sind durch syndromal gehäufte syn- oder metachrone Tumoren beim betroffenen Patienten und seiner Familie gekennzeichnet. Dabei können eine Reihe besonderer histopathologischer Befunde erhoben werden. Grundsätzlich ist zwischen Karzinomsyndromen mit Ausbildung von adenomatösen und relativ seltenen nicht-adenomatösen (hamartomatösen) Polypen zu unterscheiden. Bereits das Patientenalter kann dem Pathologen einen ersten Hinweis auf Erblichkeit geben. Die Stufendiagnostik umfasst zunächst die Tumoranalyse auf Mikrosatelliteninstabilität (MSI) mit ggf. auch vorgeschaltetem immunhistochemischem Nachweis des für MSI ursächlichen Reparaturgenverlustes (MSH2, MSH6; MLH1, PMS2). Die letzte (dritte) Diagnosestufe zielt auf den Mutationsnachweis im Blut (Keimbahnanalyse). Sie erfordert eine eingehende humangenetische Beratung und schriftliche Einwilligung des Patienten.
Abstract
Although twin studies indicate that inherited genetic factors contribute to about 35% of colorectal cancers (CRC), the exact genetic background has currently been elucidated in only 5–10% of cases. These comprise several hereditary cancer predisposition syndromes that present with a high number of syn- or metachronous neoplasms within an affected person and/or family. Many of these tumors exhibit typical histopathological changes.
In general, one should discriminate between cancer syndromes associated with adenomatous and non-adenomatous (i.e., hamartomatous) polyps, the latter being quite rare.
The patient’s age often serves as a substantial hint to hereditary cancer. The next step of diagnostic work-up includes analysis of microsatellite instability (MSI) together with immunohistochemical detection of a loss of expression in one of the most frequently affected mismatch repair genes (MSH2, MSH6; MLH1, PMS2). Finally, the molecular demonstration of a gene mutation in the blood or germline is the most expensive and tedious procedure. This requires a signed informed consent from the patient after appropriate genetic counseling.
Literatur
Aaltonen LA (1998) Molecular epidemiology of hereditary nonpolyposis colorectal cancer in Finnland. Rec Res Cancer Res 154:306–311
Aaltonen LA, Peltomäki P, Mecklin JP et al. (1994) Replication errors in benign and malignant tumors from hereditary nonpolyposis colorectal cancer patients. Cancer Res 54:1645–1648
Alexander J, Watanabe T, Wu T-T et al. (2001) Histopathological identification of colon cancer with microsatellite instability. Am J Pathol 158:527–535
Bethesda Guideline Workshop (2003) Revised guidelines for hereditary non-polyposis colorectal cancer and microsatellite instability. Meeting Summary, 3rd „International Workshop on Diagnostic Guidelines for Hereditary Non-Polyposis Colorectal Cancer and Microsatellite Instability“, Bethesda 11.–13.12.2002 (Meeting summary: Umar A et al. JNCI, accepted)
Boland CR, Thibodeau SN, Hamilton SR et al. (1998) A National Cancer Institute Workshop on Microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 58:5248–5257
Cunningham JM, Kim CY, Christensen ER et al. (2001) The frequency of hereditary defective mismatch repair in a prospective series of unselected colorectal carcinomas. Am J Hum Genet 69:780–790
Fishel R, Lescoe MK, Rao MRS et al. (1993) The human mutator gene homologue MSH2 and its association with hereditary non-polyposis colon cancer. Cell 75:1027–1038
Friedl W, Caspari R, Sengteller M et al. (2001) Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Experience from 680 FAP Families. Gut 48:515–521
Friedl W, Uhlhaas S, Schulmann K et al. (2002) Juvenile polyposis: massive gastric polyposis is more common in MADH4 mutation carriers than in BMPR1A mutation carriers. Hum Genet 111:108–111
Hamilton SR, Aaltonen LA (2000) Pathology and genetics of tumours of the digestive system. WHO, IARC, Lyon
Hartmann A, Zanardo L, Bocker-Edmonston T et al. (2002) Frequent microsatellite instability in sporadic tumors of the upper urinary tract. Cancer Res 62:6796–6802
Heinmoller E, Renke B, Beyser K et al. (2001) Pitfalls in diagnostic molecular pathology—significance of sampling error. Virchows Arch 439:504–511
Jass JR, Do KA, Simms LA et al. (1998) Morphology of sporadic colorectal cancer with DNA replication errors. Gut 47:597–602
Lanza G, Gafa R, Maestri I et al. (2002) Immunohistochemical pattern of MLH1/MSH2 expression is related to clinical and pathological features in colorectal adenocarcinomas with microsatellite instability. Mod Pathol 15:741–749
Lichtenstein P, Holm NV, Verkasalo PK et al. (2000) Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 343:78–85
Lindor NM, Burgart LJ, Leontovich O et al. (2002) Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors. J Clin Oncol 20:1043–1048
Lothe RA, Peltomäki P, Meling Gl et al. (1993) Genomic instability in colorectal cancer: Relationship to clinicopathological variables and family history. Cancer Res 53:5849–5852
Lynch HT, Smyrk T, Lynch JF (1996) Overview of natural history, pathology, molecular genetics and management of HNPCC (Lynch syndrome). Int J Cancer 69:38–43
Lynch HT, de la Chapelle A (2003) Hereditary colorectal cancer. New Engl J Med 348:919–932
Mathiak M, Rutten A, Mangold E et al. (2002) Loss of DNA mismatch repair proteins in skin tumors from patients with Muir-Torre syndrome and MSH2 or MLH1 germline mutations: establishment of immunohistochemical analysis as a screening test. Am J Surg Pathos 26:338–343
Müller A, Edmonston TB, Corao DA et al. (2002) Exclusion of breast cancer as an integral tumor of hereditary nonpolyposis colorectal cancer. Cancer Res 62:1014–1019
Müller W, Burgart L, Krause-Paulus R et al. and ICG-HNPCC (2001) The reliability of immunohistochemistry as a prescreening method of the diagnosis of hereditary nonpolyposis colorectal cancer (HNPCC)—Results of an international collaborative study. Familial Cancer 1:87–93
Paraf F, Gilquin M, Longy M et al. (2001) MLH1 and MSH2 protein immunohistochemistry is useful for detection of hereditary non-polyposis colorectal cancer in young patients. Histopathology 39:250–258
Park JG, Vasen HF, Park YJ et al. (2002) Suspected HNPCC and Amsterdam criteria II: evaluation of mutation detection rate, an international collaborative study. Int J Colorectal Dis 17:109–114
Peltomäki P, Vasen HFA and the ICG-HNPCC (1997) Mutations predisposing to hereditary nonpolyposis colorectal cancer: Database and results of a collaborative study. Gastroenterology 113:1146–1158
Ponds de Leon M, Sassatelli R, Benatti P, Roncucci L (1993) Identification of hereditary nonpolyposis colorectal cancer in the general population: the 6-year experience of a population-based registry. Cancer 71:3493–3501
Rodriguez-Bigas MA, Boland R, Hamilton SR et al. (1997) A National Cancer Institute workshop on hereditary nonpolyposis colorectal cancer syndrome: meeting highlights and Bethesda guidelines. J Natl Cancer Inst 89:1758–1762
Rüschoff J, Dietmaier W, Lüttges J et al. (1997) Poorly differentiated colonic adenocarcinoma, medullary type. Clinical, phenotypic, and molecular characteristics. Am J Pathol 150:1815–1825
Smyrk TC, Watson P, Kaul K, Lynch HT (2001) Tumor-infiltrating lymphocytes are a marker for microsatellite instability in colorectal cancer. Cancer 91:2417–2422
Thibodeau SN, Bren G, Schaid (1993) Microsatellite instability in cancer of the proximal colon. Science 260:816–819
Wirtzfeld DA, Petrelli NJ, Rodriguez-Bigas MA (2001) Hamartomatous polyposis syndromes: molecular genetics, neoplastic risk, and surveillance recommendations. Ann Surg Oncol 8:319–327
Young J, Simms LA, Biden KG et al. (2001) Features of colorectal cancers with high-level microsatellite instability occurring in familial and sporadic settings: parallel pathways of tumorigenesis. Am J Pathol 159:2107–2116
Zhou XP, Woodford-Richens K, Lehtonen R et al. (2001) Germline mutations in BMPR1A/ALK3 cause a subset of cases of juvenile polyposis syndrome and of Cowden and Bannayan-Riley-Ruvalcaba syndromes. Am J Hum Genet 69:704–711
Enholm S, Hienonen T, Suomalainen A et al. (2003) Proportion and phenotype of MYH-associated colorectal neoplasia in a population-based series of Finnish colorectal cancer patients. Am J Pathol 163:827–832
Danksagung
Die Autoren danken der Deutschen Krebshilfe für die großzügige Förderung im Rahmen des Verbundprojektes „Krebsvorsorge und Krebsfrüherkennung bei Familiärem Darmkrebs“.
Author information
Authors and Affiliations
Corresponding author
Additional information
Herrn Prof. Dr. Dr. h.c. R. Fischer in dankbarer Anerkennung seiner Arbeit als Vorsitzender des Medizinischen Beirates der Deutschen Krebshilfe (1990–2003).
Rights and permissions
About this article
Cite this article
Rüschoff, J., Roggendorf, B., Brasch, F. et al. Molekularpathologische Diagnostik beim erblichen Dickdarmkarzinom. Pathologe 25, 178–192 (2004). https://doi.org/10.1007/s00292-003-0641-x
Issue Date:
DOI: https://doi.org/10.1007/s00292-003-0641-x
Schlüsselwörter
- Erbliche Dickdarmkarzinomsyndrome.
- HNPCC
- Diagnostische Histopathologie
- Polypöse und nicht-polypöse Syndrome
- Molekularpathologie